WeChat

How do medical tapes for surgery get tested for sterility?

Madelon Meulenbelt ·

Medical tapes for surgery are tested for sterility through a process called sterility validation, which combines sterilization method development, microbial challenge testing, and packaging integrity assessment. The testing does not simply check finished products at random; it validates that the entire manufacturing and sterilization process reliably produces sterile products every time. The sections below walk through each stage of that process, from the standards that govern it to what happens when something goes wrong.

What sterility standards apply to surgical medical tapes?

Surgical medical tapes must meet the sterility requirements set out in ISO 11135 (for ethylene oxide sterilization), ISO 11137 (for radiation sterilization), and ISO 11607 (for sterile barrier packaging). In the European Union, compliance with these harmonized standards is required under the Medical Device Regulation (EU) 2017/745 (MDR), which governs all CE-marked medical devices supplied as sterile.

These standards do not define a single universal test. Instead, they set out the framework that manufacturers must follow to demonstrate that their chosen sterilization method works consistently and that the sterile barrier remains intact through distribution and storage. The specific standard that applies depends on the sterilization method selected: ethylene oxide, gamma radiation, electron beam, or steam, and each comes with its own validation requirements.

For surgical adhesive tapes and films used in single-use procedure packs, the MDR also requires that manufacturers maintain a quality management system certified to ISO 13485. This standard governs the entire production environment, not just sterilization, and ensures that processes are documented, controlled, and subject to ongoing audit. Together, these standards create a layered framework that any sterile surgical tape must satisfy before it reaches the operating room.

How are medical tapes sterilized before reaching the operating room?

Most surgical medical tapes and adhesive films are sterilized using ethylene oxide (EtO) or gamma radiation, both of which are compatible with the polymers, adhesives, and nonwoven materials typically used in these products. The choice of method depends on the material composition of the tape, its packaging, and the volume and throughput requirements of the manufacturer.

Ethylene oxide is a gas that penetrates packaging and kills microorganisms by disrupting their cellular processes. It is widely used for adhesive medical products because it operates at relatively low temperatures, which protects heat-sensitive materials. After EtO treatment, products must go through a controlled aeration cycle to remove residual gas before they are safe to handle and use.

Gamma radiation and electron beam sterilization work by delivering ionizing energy that damages microbial DNA. These methods are faster than EtO and leave no chemical residue, but they can affect some adhesive formulations or polymers over time, so material compatibility testing is a required part of the validation process. Whichever method is selected, the sterilization cycle must be validated before it is used in production, and each production batch must be processed under the same controlled parameters.

What does sterility testing for surgical tapes actually involve?

Sterility testing for surgical tapes involves a combination of bioburden assessment, sterilization dose validation, and sterility assurance level (SAL) verification. The goal is to confirm that the sterilization process reduces the probability of a viable microorganism remaining on any single unit to one in one million, expressed as a SAL of 10-6.

Bioburden assessment

Before sterilization, manufacturers measure the bioburden, the number and types of microorganisms naturally present on the product and its packaging. This baseline measurement directly informs the sterilization dose or cycle parameters needed to achieve the required SAL. Bioburden testing follows ISO 11737-1 and is repeated at defined intervals to monitor consistency across production batches.

Dose validation and sterility assurance

For radiation sterilization, dose validation involves exposing product samples to a calculated minimum dose and then testing for surviving microorganisms. For EtO, validation involves running the sterilization cycle at defined parameters of gas concentration, temperature, humidity, and exposure time, then testing whether the cycle consistently eliminates a defined microbial challenge. These validation studies must be repeated or reviewed whenever the product, process, or materials change in any meaningful way.

Why can’t sterility be verified by testing alone?

Sterility cannot be verified by end-product testing alone because testing a sample of finished units cannot prove that every unit in a batch is sterile. Even a large sample represents only a fraction of the total batch, and a sterility test on a sample that passes gives no guarantee about the units not tested. This is a fundamental statistical limitation, not a gap in testing technology.

This is why regulatory standards require process validation rather than product testing as the primary assurance mechanism. The logic is straightforward: if you can demonstrate that the sterilization process reliably achieves the required SAL under controlled conditions, and if you can show that every production batch runs under those same conditions, then every batch can be released with confidence, without testing every unit.

End-product sterility testing, as described in ISO 11737-2, still has a role, but it is used to support validation studies and investigate failures rather than to serve as routine batch release testing. Manufacturers who rely on single-use surgical products need to understand this distinction, because it shifts the quality assurance burden upstream, into process design, material control, and manufacturing consistency.

How does packaging affect sterility of surgical medical tapes?

Packaging is a critical part of sterility assurance because it maintains the sterile barrier from the point of sterilization through to the moment of use. If the packaging fails at any point during storage, transport, or handling, the product inside is no longer considered sterile, regardless of how well the sterilization process performed.

ISO 11607 sets out the requirements for sterile barrier systems and protective packaging for terminally sterilized medical devices. For surgical tapes and films, this typically means a combination of a porous material that allows the sterilant to penetrate during processing and a seal that prevents microbial ingress afterward. The integrity of that seal must be validated through testing that simulates the physical stresses of distribution, including compression, vibration, and temperature variation.

Packaging validation also considers the shelf life of the product. Manufacturers must demonstrate that the sterile barrier remains intact for the intended storage period, which requires accelerated aging studies or real-time aging data. Any change to the packaging material, supplier, seal parameters, or product dimensions requires revalidation. For manufacturers assembling custom procedure packs, the interaction between the tape component and the outer pack packaging must also be assessed, since the final sterile barrier is the pack itself.

What happens when a surgical tape fails sterility validation?

When a surgical tape fails sterility validation, the manufacturer must quarantine the affected batch, investigate the root cause, and demonstrate that the failure has been corrected before releasing any further product. A validation failure does not automatically mean the product is non-sterile, but it does mean the manufacturer cannot provide the documented assurance required by regulation.

The investigation process typically follows a structured corrective and preventive action (CAPA) framework, which is a requirement under ISO 13485. The manufacturer must identify whether the failure originated in the sterilization process itself, in the bioburden of incoming materials, in a packaging seal, or in a deviation from the validated process parameters. Each root cause leads to a different corrective action: adjusting cycle parameters, tightening material controls, requalifying a packaging supplier, or retraining operators.

If the failure points to a systemic problem rather than an isolated event, the manufacturer may need to conduct a full revalidation study before resuming production. In some cases, a market withdrawal or field safety corrective action may be required if already-distributed product is affected. Regulatory bodies, including the European competent authorities, expect manufacturers to report serious failures and to document the full investigation and resolution. This is one reason why robust process monitoring and in-process controls matter so much: catching a deviation early, before it becomes a validation failure, is far less disruptive than managing one after the fact.

How SOMED supports sterility-compliant surgical tape manufacturing

At SOMED, we develop and manufacture adhesive tapes and films for surgical applications with sterility compliance built into the process from the start. We work with procedure pack assemblers, surgical drape manufacturers, and medical device distributors who need components that integrate cleanly into their own validated sterile systems. Here is what that means in practice:

  • MDR-compliant products: All our surgical adhesive tapes and films are CE-marked and manufactured in accordance with applicable ISO standards, including ISO 13485, so they are ready to incorporate into your procedure pack without adding a compliance burden.
  • In-house adhesive and tape development: We develop and produce our adhesives in-house, which gives us direct control over material consistency, one of the key variables in bioburden management and sterilization compatibility.
  • Flexible, small-volume manufacturing: We work with customers who are developing new products or features, including at volumes that many larger manufacturers would not support. If you are validating a new pack configuration, we can supply components at the scale you need for your validation studies.
  • Technical support for integration: Our team can assist on-site and help you understand how our products interact with your packaging and sterilization process, useful when you are working through packaging validation or addressing a compatibility question.

If you are sourcing sterile-compatible adhesive components for a surgical drape or procedure pack, we are happy to discuss your requirements. Get in touch with our team to start the conversation.

Related Articles

This content was generated with the help of AI and it may contain mistakes